James P Zacny1, Sandra Gutierrez. 1. Department of Anesthesia and Critical Care MC4028, The University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. jzacny@dacc.uchicago.edu
Abstract
RATIONALE: Nonmedical use of prescription opioids is sometimes accompanied by the ingestion of ethanol. Whether ethanol increases the abuse liability-related effects of prescription opioids has not been determined. OBJECTIVE: The purpose of this study was to characterize the subjective, psychomotor, and physiological effects of oxycodone, a widely prescribed and abused opioid, and ethanol, alone and in combination. METHODS:Fourteen volunteers participated in a randomized, crossover trial in which they were exposed to placebo, oxycodone (10 mg), two doses of ethanol (0.3 and 0.6 g/kg), and oxycodone combined with the lower dose and the higher dose of ethanol on separate sessions. RESULTS:Several abuse liability-related subjective effects (drug liking, take again, pleasant bodily sensations) were not increased by the low dose of ethanol or oxycodone alone relative to placebo, but were when the two were combined. Self-reported liking of the higher dose of ethanol was higher than that of placebo, but oxycodone neither increased nor decreased this effect. Psychomotor and cognitive performance was not affected by any of the active drug conditions. Absorption of ethanol was decreased by oxycodone. CONCLUSIONS: In this study, 10 mg of oral oxycodone combined with a low dose of ethanol generated abuse liability-related effects, but when tested separately, they did not. Further psychopharmacological investigations of this combination are warranted in light of these findings and the fact that nonmedical use of prescription opioids is sometimes accompanied by use of ethanol.
RCT Entities:
RATIONALE: Nonmedical use of prescription opioids is sometimes accompanied by the ingestion of ethanol. Whether ethanol increases the abuse liability-related effects of prescription opioids has not been determined. OBJECTIVE: The purpose of this study was to characterize the subjective, psychomotor, and physiological effects of oxycodone, a widely prescribed and abused opioid, and ethanol, alone and in combination. METHODS: Fourteen volunteers participated in a randomized, crossover trial in which they were exposed to placebo, oxycodone (10 mg), two doses of ethanol (0.3 and 0.6 g/kg), and oxycodone combined with the lower dose and the higher dose of ethanol on separate sessions. RESULTS: Several abuse liability-related subjective effects (drug liking, take again, pleasant bodily sensations) were not increased by the low dose of ethanol or oxycodone alone relative to placebo, but were when the two were combined. Self-reported liking of the higher dose of ethanol was higher than that of placebo, but oxycodone neither increased nor decreased this effect. Psychomotor and cognitive performance was not affected by any of the active drug conditions. Absorption of ethanol was decreased by oxycodone. CONCLUSIONS: In this study, 10 mg of oral oxycodone combined with a low dose of ethanol generated abuse liability-related effects, but when tested separately, they did not. Further psychopharmacological investigations of this combination are warranted in light of these findings and the fact that nonmedical use of prescription opioids is sometimes accompanied by use of ethanol.
Authors: Laura M Garnier; Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Kevin E O'Grady; Eric D Wish Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: C Girre; M Hirschhorn; L Bertaux; S Palombo; F Dellatolas; R Ngo; M Moreno; P E Fournier Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953
Authors: Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman Journal: Pharmacol Biochem Behav Date: 2021-11-04 Impact factor: 3.533
Authors: Shanna Babalonis; Marion A Coe; Paul A Nuzzo; Michelle R Lofwall; Nur Ali; Paul A Sloan; Laura C Fanucchi; Sharon L Walsh Journal: Psychopharmacology (Berl) Date: 2020-11-09 Impact factor: 4.530